| Host: |
Goat |
| Applications: |
Pep-ELISA/WB |
| Reactivity: |
Mouse/Rat |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Goat polyclonal antibody anti-FHL1/SLIM1 (Internal) is suitable for use in ELISA and Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA |
| Purification: |
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
| Concentration: |
0.5 mg/mL |
| Dilution Range: |
WB-0.05-0.3µg/mlIHC-2µg/mlELISA-antibody detection limit dilution 1:32000. |
| Storage Instruction: |
Store at-20°C on receipt and minimise freeze-thaw cycles. |
| Gene Symbol: |
FHL1 |
| Gene ID: |
2273 |
| Uniprot ID: |
FHL1_HUMAN |
| Immunogen Region: |
Internal |
| Accession Number: |
NP_001440.2; NP_001153171.1 |
| Specificity: |
This antibody is expected to recognise isoforms 2 (NP_001440.1) and 5 (NP_001153171.1). Since June 2009 the second N residue in the immunizing peptide is no longer representative as it has been substituted by Q at position 284 of NP_001440.2. Variant |
| Immunogen Sequence: |
CNKRFVFHNEQVY |
| Function | May have an involvement in muscle development or hypertrophy. |
| Protein Name | Four And A Half Lim Domains Protein 1Fhl-1Skeletal Muscle Lim-Protein 1SlimSlim-1 |
| Cellular Localisation | Isoform 1: CytoplasmIsoform 3: CytoplasmNucleusIsoform 2: NucleusCytoplasmCytosolPredominantly Nuclear In Myoblasts But Is Cytosolic In Differentiated Myotubes |
| Alternative Antibody Names | Anti-Four And A Half Lim Domains Protein 1 antibodyAnti-Fhl-1 antibodyAnti-Skeletal Muscle Lim-Protein 1 antibodyAnti-Slim antibodyAnti-Slim-1 antibodyAnti-FHL1 antibodyAnti-SLIM1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
